39 related articles for article (PubMed ID: 2042686)
1. Octreotide in Hennekam syndrome-associated intestinal lymphangiectasia.
Al Sinani S; Rawahi YA; Abdoon H
World J Gastroenterol; 2012 Nov; 18(43):6333-7. PubMed ID: 23180957
[TBL] [Abstract][Full Text] [Related]
2. Graft-versus-host-like colitis and malignant thymoma.
Lowry PW; Myers JD; Geller A; Bostwick DG; Clain JE
Dig Dis Sci; 2002 Sep; 47(9):1998-2001. PubMed ID: 12353844
[No Abstract] [Full Text] [Related]
3. Tumor-related dysmotility: gastrointestinal dysmotility syndromes associated with tumors.
DiBaise JK; Quigley EM
Dig Dis Sci; 1998 Jul; 43(7):1369-401. PubMed ID: 9690371
[No Abstract] [Full Text] [Related]
4. Consensus statement: octreotide dose titration in secretory diarrhea. Diarrhea Management Consensus Development Panel.
Harris AG; O'Dorisio TM; Woltering EA; Anthony LB; Burton FR; Geller RB; Grendell JH; Levin B; Redfern JS
Dig Dis Sci; 1995 Jul; 40(7):1464-73. PubMed ID: 7628270
[TBL] [Abstract][Full Text] [Related]
5. Antidiarrheal agents for the management of treatment-related diarrhea in cancer patients.
Ippoliti C
Am J Health Syst Pharm; 1998 Aug; 55(15):1573-80. PubMed ID: 9706182
[TBL] [Abstract][Full Text] [Related]
6. Use of octreotide in the symptomatic management of diarrhea induced by graft-versus-host disease in patients with hematologic malignancies.
Ippoliti C; Champlin R; Bugazia N; Przepiorka D; Neumann J; Giralt S; Khouri I; Gajewski J
J Clin Oncol; 1997 Nov; 15(11):3350-4. PubMed ID: 9363865
[TBL] [Abstract][Full Text] [Related]
7. Octreotide in the management of diarrhea induced by graft versus host disease.
Ippoliti C; Neumann J
Oncol Nurs Forum; 1998 Jun; 25(5):873-8. PubMed ID: 9644703
[TBL] [Abstract][Full Text] [Related]
8. Continuous octreotide infusion for the treatment of secretory diarrhea caused by acute intestinal graft-versus-host disease in a child.
Beckman RA; Siden R; Yanik GA; Levine JE
J Pediatr Hematol Oncol; 2000; 22(4):344-50. PubMed ID: 10959906
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of octreotide in controlling refractory diarrhea following bone marrow transplantation.
Morton AJ; Durrant ST
Clin Transplant; 1995 Jun; 9(3 Pt 1):205-8. PubMed ID: 7549062
[TBL] [Abstract][Full Text] [Related]
10. The somatostatin analog octreotide in the management of the secretory diarrhea of the acute intestinal graft-versus-host disease in a patient after bone marrow transplantation.
Bianco JA; Higano C; Singer J; Appelbaum FR; McDonald GB
Transplantation; 1990 Jun; 49(6):1194-5. PubMed ID: 2360261
[No Abstract] [Full Text] [Related]
11. Use of a somatostatin analogue, octreotide acetate, in the management of acute gastrointestinal graft-versus-host disease.
Ely P; Dunitz J; Rogosheske J; Weisdorf D
Am J Med; 1991 Jun; 90(6):707-10. PubMed ID: 2042686
[TBL] [Abstract][Full Text] [Related]
12. The role of somatostatin analogues in the treatment of refractory diarrhoea.
Farthing MJ
Digestion; 1996; 57 Suppl 1():107-13. PubMed ID: 8813486
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
